BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3744579)

  • 21. Function of phagocytes in experimentally induced colitis in rabbits. II. The Shwartzman phenomenon in the colon.
    Hermanowicz A; Hermel A; Nowak A; Sliwiński Z; Nawarska Z; Borys D; Banaś B
    Int Arch Allergy Appl Immunol; 1986; 80(3):245-52. PubMed ID: 3721594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Function of exudative neutrophilic granulocytes in patients with Crohn's disease or ulcerative colitis.
    Wandall JH
    Scand J Gastroenterol; 1985 Nov; 20(9):1151-6. PubMed ID: 4089525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psoriasis and leukocyte chemotaxis.
    Tagami H; Iwatsuki K; Takematsu H
    J Invest Dermatol; 1987 Mar; 88(3 Suppl):18s-23s. PubMed ID: 3493302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased serum concentrations and surface expression on peripheral white blood cells of decay-accelerating factor (CD55) in patients with active ulcerative colitis.
    Makidono C; Mizuno M; Nasu J; Hiraoka S; Okada H; Yamamoto K; Fujita T; Shiratori Y
    J Lab Clin Med; 2004 Mar; 143(3):152-8. PubMed ID: 15007304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ontogeny of neutrophil chemotaxis in fetal lambs.
    Raghunathan R; Faust J; Misra S; Miller ME
    Pediatr Res; 1986 Mar; 20(3):265-8. PubMed ID: 3703615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of a neutrophil chemotactic agent by spermatozoa: role of complement and regulation by seminal plasma factors.
    Clark RA; Klebanoff SJ
    J Immunol; 1976 Oct; 117(4):1378-86. PubMed ID: 977954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defective serum chemotactic capacity in rheumatoid arthritis.
    Attia WM; Ali MK; Abu-Ghazalah LM; Shams AH; Clark HW; Brown TM; Bellanti JA
    Ann Allergy; 1983 Apr; 50(4):266-70. PubMed ID: 6838025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease.
    Mitsuyama K; Toyonaga A; Sasaki E; Watanabe K; Tateishi H; Nishiyama T; Saiki T; Ikeda H; Tsuruta O; Tanikawa K
    Clin Exp Immunol; 1994 Jun; 96(3):432-6. PubMed ID: 8004812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of neutrophil chemotaxis and chemokinesis associated with a plasma protein in aging rats: selective depression of cell responses mediated by complement-derived chemoattractants.
    Mello SB; Farsky SH; Sannomiya P; Garcia-Leme J
    J Leukoc Biol; 1992 Jan; 51(1):46-52. PubMed ID: 1311013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotactic responsiveness and random motility of polymorphonuclear leukocytes from patients with progressive systemic sclerosis.
    Minta JO; Kovacs EK; Sukenik S; Lee P
    J Rheumatol; 1985 Dec; 12(6):1125-8. PubMed ID: 4093918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotactic peptides modulate adherence of human polymorphonuclear leukocytes to monolayers of cultured endothelial cells.
    Charo IF; Yuen C; Perez HD; Goldstein IM
    J Immunol; 1986 May; 136(9):3412-9. PubMed ID: 3514759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A neutrophil-immobilizing factor derived from human leukocytes. I. Generation and partial characterization.
    Goetzl EJ; Austen KF
    J Exp Med; 1972 Dec; 136(6):1564-80. PubMed ID: 4641855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism for the inflammatory response in primate lungs. Demonstration and partial characterization of an alveolar macrophage-derived chemotactic factor with preferential activity for polymorphonuclear leukocytes.
    Kazmierowski JA; Gallin JI; Reynolds HY
    J Clin Invest; 1977 Feb; 59(2):273-81. PubMed ID: 401834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study of chemotactic activity developed by neutrophils from rheumatoid arthritis patients.
    Bostan M; Constantin MC; Nicolau A; Hirt M; Galatiuc C; Matei I; Braşoveanu LI; Iordăchescu D
    Roum Arch Microbiol Immunol; 2002; 61(4):243-58. PubMed ID: 15055258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITRO.
    WARD PA; COCHRANE CG; MUELLER-EBERHARD HJ
    J Exp Med; 1965 Aug; 122(2):327-46. PubMed ID: 14316948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of the alternative complement pathway and generation of stimulating factors for granulocytes by glass fibers.
    Governa M; Valentino M; Visona I; Marchiseppe I; Lo Martire N
    Cell Biol Toxicol; 1988 Jun; 4(2):187-97. PubMed ID: 2852993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1).
    Yoshimura T; Matsushima K; Oppenheim JJ; Leonard EJ
    J Immunol; 1987 Aug; 139(3):788-93. PubMed ID: 3298433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defective T-lymphocyte chemotactic factor production in patients with established malignancy.
    Cole D; Van Epps DE; Williams RC
    Clin Immunol Immunopathol; 1986 Feb; 38(2):209-21. PubMed ID: 2934199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spontaneous aggregation of leukocytes in active ulcerative colitis might be ICAM-1 dependent.
    Vainer B; Berliner S; Nielsen OH
    Inflamm Res; 2004 Sep; 53(9):458-61. PubMed ID: 15550998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of neutrophil migratory function in burn injury by complement activation products.
    Solomkin JS; Nelson RD; Chenoweth DE; Solem LD; Simmons RL
    Ann Surg; 1984 Dec; 200(6):742-6. PubMed ID: 6508405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.